Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Head and Neck Cancer Drug Development Summit

Evvnt Promotion / evvnt
Archiv
-
30.11.2021 - 01.12.2021  Virtual
Time: 09:00 to 15:00
 
Kongressthemen
The Head and Neck Cancer Drug Development Summit has been curated with the industry in mind. Development in the head and neck cancer space has entered the most active period to date, with emerging immunotherapy biotechs, leading biopharma companies, and pioneering academics racing to exploit this immunogenic tumor, validate early clinical data from broader solid tumor trials, and improve clinical outcomes in this indication with a high unmet medical need.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/842127-0?pid=4832


Speakers: Lars Birgerson, Chief Executive Officer, Adlai Nortye, Sophia Randolph, Chief Medical Officer, Alexo Therapeutics Inc., Michael Needle, Chief Medical Officer, AVEO Oncology, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/842127-2?pid=4832
Herr Customer Service
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
Industry Rate - Early Bird 1 Pricing (save $500): USD 1599.00, Industry Rate - Final Price: USD 2099.00, Solution Provider Rate - Early Bird 1 Pricing (save $700): USD 1899.00, Solution Provider Rate - Final Price: USD 2599.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellencenewTreeHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der WeltEuropean Health Forum GasteinAnästhesie in Entwicklungsländern e. V.